Private Management Group Inc. Has $20.38 Million Position in Avantor, Inc. $AVTR

Key Points

• Private Management Group increased its stake in Avantor by 20.7% in Q3 to 1,633,287 shares, a holding worth about $20.38 million (0.24% of the company) per its latest 13F filing.
• Company insiders bought 275,000 shares (~$2.4M) this quarter, including directors Gregory L. Summe (100,000 shares at $9.40) and Sanjeev K. Mehra (125,000 shares at $8.01), raising insider ownership to about 1.20%.
• Wall Street consensus is "Hold" with an average target of $11.80, while Avantor shares traded around $7.94 (52-week range $7.82–$17.11) and the company set FY2026 EPS guidance of $0.77–$0.83.

Private Management Group Inc. raised its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 20.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,633,287 shares of the company's stock after purchasing an additional 280,156 shares during the quarter. Private Management Group Inc. owned 0.24% of Avantor worth $20,383,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its holdings in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock worth $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC bought a new position in Avantor in the 2nd quarter valued at approximately $32,000. Osaic Holdings Inc. raised its holdings in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock valued at $38,000 after buying an additional 1,064 shares during the last quarter. Farther Finance Advisors LLC boosted its position in Avantor by 172.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company's stock worth $46,000 after buying an additional 2,346 shares during the period. Finally, Allworth Financial LP boosted its position in Avantor by 110.0% during the 2nd quarter. Allworth Financial LP now owns 3,740 shares of the company's stock worth $50,000 after buying an additional 1,959 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Avantor

In other news, Director Gregory L. Summe bought 100,000 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The shares were acquired at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the completion of the acquisition, the director directly owned 400,000 shares in the company, valued at approximately $3,760,000. This represents a 33.33% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Sanjeev K. Mehra purchased 125,000 shares of the business's stock in a transaction on Tuesday, March 10th. The shares were purchased at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the transaction, the director directly owned 475,000 shares of the company's stock, valued at approximately $3,804,750. The trade was a 35.71% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 275,000 shares of company stock worth $2,399,250 over the last quarter. Company insiders own 1.20% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Bank of America cut shares of Avantor from a "buy" rating to a "neutral" rating and set a $13.00 price target for the company. in a research report on Monday, December 15th. Wells Fargo & Company cut their price target on shares of Avantor from $16.00 to $14.00 and set an "overweight" rating on the stock in a report on Friday, February 13th. Morgan Stanley set a $10.00 price objective on shares of Avantor in a research note on Friday, February 13th. Evercore set a $10.00 price objective on Avantor in a report on Wednesday, February 11th. Finally, Barclays reaffirmed an "underweight" rating and set a $8.50 target price on shares of Avantor in a research report on Friday, March 6th. Three analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, Avantor presently has a consensus rating of "Hold" and an average target price of $11.80.

Avantor Stock Up 0.5%

Avantor stock opened at $7.94 on Friday. The firm has a market cap of $5.41 billion, a price-to-earnings ratio of -10.18, a PEG ratio of 3.10 and a beta of 0.97. Avantor, Inc. has a 52-week low of $7.82 and a 52-week high of $17.11. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78. The firm has a 50 day moving average price of $10.36 and a two-hundred day moving average price of $11.69.

Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The company had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the firm posted $0.27 EPS. The company's quarterly revenue was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Equities analysts predict that Avantor, Inc. will post 1.06 EPS for the current year.

Avantor Company Profile

Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor's offerings are organized across two primary segments.

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.